Your study found that analyzing specific bacterial groups in the in the gut could predict melanoma recurrence with a very ...
Cancer care is not experienced equally across the globe. Speaking at the 2026 NCCN Annual Conference, Caroline Taylor, ...
Rezetapopt demonstrated a 44.4% overall response rate and durable responses lasting over eight months in patients with ...
Rezetapopt showed a 44.4% response rate and durable responses over 8 months in ovarian cancer with p53 Y220C mutation, with mostly mild side effects.
Dietitian Stephanie Meyers shared practical strategies at the LiveLung SCLC Patient Summit to help patients manage appetite ...
Dietitian Stephanie Meyers shared practical strategies at the LiveLung SCLC Patient Summit to help patients manage appetite loss and digestive issues.
At the 2026 NCCN Annual Meeting, CURE sat down with Dr. Thomas Flaig to discuss the rapidly evolving landscape of bladder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results